On Wednesday March 25, 2020 the House and Senate passed Bill C-13, an emergency federal bill that provides for compulsory licenses for technologies relating to the health emergency on a time limited basis. Other countries have also been considering compulsory licensing options. Lawmakers in Chile and Ecuador have each passed resolutions urging their governments to explore compulsory licensing options. Israel has also permitted companies to produce a generic version of the Kaletra HIV pill owned by AbbVie despite the patent term not expiring until 2024.
To view the original article, please click here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
